Vident Advisory, LLC: GSK position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Vident Advisory, LLC on GSK, newest first. How the timeline and the estimate are built.
Vident Advisory, LLC held 37,908 GSK shares at 2026-06-30 per its 13F-HR filed 2026-08-12.
the latest 13F is the newest step
- period ended2026-06-3013F 37,908 sharesChange vs previous 13F +925 shares
0.01% of the 13F portfolio, value $1,987,132.
13F-HR 0001172661-26-003342 filed by Vident Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 36,983 sharesChange vs previous 13F +9,064 shares
0.02% of the 13F portfolio, value $2,041,139.
13F-HR 0001172661-26-001995 filed by Vident Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 27,919 sharesChange vs previous 13F +689 shares
0.01% of the 13F portfolio, value $1,369,188.
13F-HR 0001172661-26-001275 filed by Vident Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 27,230 sharesChange vs previous 13F -287 shares
0.01% of the 13F portfolio, value $1,175,225.
13F-HR 0001172661-25-004874 filed by Vident Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 27,517 sharesChange vs previous 13F -857 shares
0.01% of the 13F portfolio, value $1,056,654.
13F-HR 0001172661-25-003424 filed by Vident Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 28,374 sharesChange vs previous 13F +8,294 shares
0.02% of the 13F portfolio, value $1,099,266.
13F-HR 0001172661-25-001986 filed by Vident Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 20,080 sharesChange vs previous 13F +813 shares
0.01% of the 13F portfolio, value $679,130.
13F-HR 0001172661-25-000890 filed by Vident Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 19,267 sharesChange vs previous 13F not available
0.02% of the 13F portfolio, value $787,710.
13F-HR 0001172661-24-004772 filed by Vident Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).